Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
genmab,abbvie
['epcoritamab', 'dlbcl']
with epcoritamab-r-chop as frontline all dlbcl pts response (~80% cr), even dh and th #17icml waiting for longer follow-up and phase 3 data against r-chop 
MD at @USAL | Internal Med student at @HematoCAUSA | #cytopath #cytometry and #lymphoma at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes